# Monoclonal antibodies: Evolution

Source page: https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-evolution/

#### Timeline

The milestones from first idea to today

| Year | Milestone |
|---|---|
| 1975 | Köhler and Milstein describe the hybridoma technique ^[1] |
| 1984 | Köhler and Milstein share the Nobel Prize in Physiology or Medicine with Niels Jerne ^[1] |
| 1986 | Muromonab-CD3 (OKT3), a mouse antibody, becomes the first approved antibody medicine ^[2] |
| 1994 | The first chimeric antibody, abciximab, is approved ^[2] |
| 1997 | The first humanised antibody, daclizumab, is approved by the FDA ^[2] |
| 2002 | The first fully human antibody, adalimumab, is approved for rheumatoid arthritis; it came from Gregory Winter's phage display method ^[2]^[5] |
| 2024 | 21 antibody medicines win a first approval in one year ^[3] |

as of 2026-11-11

#### Lineage

The technologies it came from and the ones that came from it
 Builds on

- [rDNA Recombinant DNA (genetic engineering)](https://www.materialinsights.org/technologies/recombinant_dna/) Chimeric, humanised and fully human antibodies are made by engineering antibody genes, which replaced the first mouse antibodies ^[2].
 Enables

- [CAR CAR-T cell therapy](https://www.materialinsights.org/technologies/car_t_cell_therapy/) CAR T cells carry a receptor whose target-binding part is taken from an antibody.
 Works with

- [Asa Synthetic drugs (medicinal chemistry)](https://www.materialinsights.org/technologies/synthetic_drugs/) Antibodies and small-molecule drugs act in different ways and are often used side by side, for example in cancer care.
- [CCV Cell-culture viral vaccines](https://www.materialinsights.org/technologies/cell_culture_vaccines/) Vaccines teach the body to make its own antibodies; monoclonal antibodies supply ready-made ones.

as of 2026-11-11

#### Sources

1. [The Nobel Prize in Physiology or Medicine 1984: press release](https://nobelprize.org/prizes/medicine/1984/press-release) Nobel Assembly at Karolinska Institutet (nobelprize.org)
2. [Development of therapeutic antibodies for the treatment of diseases](https://pmc.ncbi.nlm.nih.gov/articles/PMC6939334) Journal of Biomedical Science 27: 1 (Lu, Hwang, Liu, Lee, Tsai, Li and Wu), on PubMed Central, 2020
3. [Antibodies to watch in 2025](https://profiles.wustl.edu/en/publications/antibodies-to-watch-in-2025/) mAbs 17(1): 2443538 (Crescioli, Kaplon, Wang, Visweswaraiah, Kapoor and Reichert), record at Washington University in St. Louis, 2025
4. [Press release: The Nobel Prize in Chemistry 2018](https://www.nobelprize.org/prizes/chemistry/2018/press-release/) Royal Swedish Academy of Sciences (nobelprize.org), 2018

## Other sections

- [Summary](https://www.materialinsights.org/technologies/monoclonal_antibodies/index.md)
- [Overview](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-science/index.md)
- [Materials](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-industries/index.md)
